KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Repurchased
Ratios

Edwards Lifesciences (EW) Long-Term Debt Issuances (2016 - 2021)

Historic Long-Term Debt Issuances for Edwards Lifesciences (EW) over the last 11 years, with Q3 2021 value amounting to -$8.8 million.

  • Edwards Lifesciences' Long-Term Debt Issuances fell 61764.71% to -$8.8 million in Q3 2021 from the same period last year, while for Jun 2022 it was -$8.8 million, marking a year-over-year decrease of 14489.8%. This contributed to the annual value of $5.2 million for FY2021, which is 6790.12% down from last year.
  • Latest data reveals that Edwards Lifesciences reported Long-Term Debt Issuances of -$8.8 million as of Q3 2021, which was down 61764.71% from $9.5 million recorded in Q2 2021.
  • In the past 5 years, Edwards Lifesciences' Long-Term Debt Issuances registered a high of $680.7 million during Q2 2018, and its lowest value of -$8.8 million during Q3 2021.
  • Moreover, its 5-year median value for Long-Term Debt Issuances was $4.5 million (2021), whereas its average is $90.7 million.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first surged by 970645.16% in 2017, then crashed by 61764.71% in 2021.
  • Over the past 5 years, Edwards Lifesciences' Long-Term Debt Issuances (Quarter) stood at $5.4 million in 2017, then plummeted by 70.37% to $1.6 million in 2018, then skyrocketed by 331.25% to $6.9 million in 2019, then crashed by 43.48% to $3.9 million in 2020, then crashed by 325.64% to -$8.8 million in 2021.
  • Its Long-Term Debt Issuances stands at -$8.8 million for Q3 2021, versus $9.5 million for Q2 2021 and $4.5 million for Q1 2021.